Scientific Sessions 2025  /  Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy  /  TAVR for All Patients
Logo

American Heart Association

  85
  0

Final ID:

TAVR for All Patients

  • Hahn, Rebecca  ( COLUMBIA UNIVERSITY , New York , New York , United States )
  • Genereux, Philippe  ( Atlantic Health , Morristown , New Jersey , United States )
  • Makkar, Raj  ( Cedar Sinai Medical Center , Los Angeles , California , United States )
  • Mehran, Roxana  ( Icahn School of Med. at Mount Sinai , New York , New York , United States )
  • Tchetche, Didier  ( CLINIQUE PASTEUR TOULOUSE , TOULOUSE , France )
  • Webb, John  ( St Paul's Hospital , Vancouver , British Columbia , Canada )
    • Author Disclosures:
    Rebecca Hahn: DO have relevant financial relationships ; Speaker:Abbott Structural:Past (completed) ; Speaker:Philips Healthcare:Active (exists now) ; Speaker:Edwards Lifescience:Active (exists now) ; Speaker:Baylis Medical:Past (completed) | Philippe Genereux: DO have relevant financial relationships ; Consultant:Edwards:Active (exists now) ; Consultant:piCardia:Active (exists now) | Raj Makkar: No Answer | Roxana Mehran: DO have relevant financial relationships ; Research Funding (PI or named investigator):Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, CPC Clinical Research, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis GmbH, RM Global Bioaccess Fund Management, Sanofi US Services, Inc.:Active (exists now) ; Other (please indicate in the box next to the company name):Honorarium: AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program):Active (exists now) ; Other (please indicate in the box next to the company name):No Fees from: SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director):Active (exists now) ; Individual Stocks/Stock Options:Elixir Medical, Stel, ControlRad (spouse):Active (exists now) ; Advisor:Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk:Active (exists now) | DIDIER TCHETCHE: No Answer | John Webb: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Case Presentation: Low-Risk Young (50-60 Years Old) Patient with Severe Symptomatic Aortic Stenosis

Hamilton Barbara, Scrimgeour Laura, Bromberger Bianca, Boskovski Marko

Survival Is Key: Ross Operation

El-hamamsy Ismail, Boskovski Marko, Tseng Elaine

More abstracts from these authors:
TAVR vs. SAVR in Low-Risk Aortic Stenosis Patients: 5-Year Outcomes Unveiled for Evolut Low-Risk

Reardon Michael, Forrest John, Popma Jeffrey, Tchetche Didier

The SMART Trial: Balloon-Expandable vs Self-Expanding TAVR in Women with Small Annuli

Mehran Roxana, Tchetche Didier, Guerrero Mayra E, Herrmann Howard

You have to be authorized to contact abstract author. Please, Login
Not Available